SEARCH

SEARCH BY CITATION

REFERENCES

  • Acarregui MJ, Brown JJ, Penisten ST. 1998. Cyclic AMP-dependent protein kinase (PKA) gene expression is developmentally regulated in fetal lung. Biochim Biophys Acta 1402: 303312.
  • Aeberhard EE, Scott ML, Barrett CT, Kaplan SA. 1984. Effects of cyclic AMP analogues and phosphodiesterase inhibitors on phospholipid biosynthesis in fetal type II pneumocytes. Biochim Biophys Acta 803: 2938.
  • Bender AT, Beavo JA. 2006. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488520.
  • Bolger GB, Erdogan S, Jones RE, Loughney K, Scotland G, Hoffmann R, Wilkinson I, Farrell C, Houslay MD. 1997. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem J 328: 539548.
  • Boswell-Smith V, Spina D. 2007. PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast. Int J Chron Obstruct Pulmon Dis 2: 121129.
  • Boucherat O, Franco-Montoya ML, Thibault C, Incitti R, Chailley-Heu B, Delacourt C, Bourbon JR. 2007. Gene expression profiling in lung fibroblasts reveals new players in alveolarization. Physiol Genomics 32: 128141.
  • Cardoso WV. 2001. Molecular regulation of lung development. Annu Rev Physiol 63: 471494.
  • Clerch LB, Baras AS, Massaro GD, Hoffman EP, Massaro D. 2004. DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation. Am J Physiol Lung Cell Mol Physiol 286: L411419.
  • Conti M, Richter W, Mehats C, Livera G, Park JY, Jin C. 2003. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 278: 54935496.
  • Finley N, Norlin A, Baines DL, Folkesson HG. 1998. Alveolar epithelial fluid clearance is mediated by endogenous catecholamines at birth in guinea pigs. J Clin Invest 101: 972981.
  • Fisher AB, Arad I, Dodia C, Chander A, Feinstein SI. 1991. cAMP increases synthesis of surfactant-associated protein A by perfused rat lung. Am J Physiol 260: L226233.
  • Foster JJ, Goss KL, George CL, Bangsund PJ, Snyder JM. 2006. Galectin-1 in secondary alveolar septae of neonatal mouse lung. Am J Physiol Lung Cell Mol Physiol 291: L11421149.
  • Iona S, Cuomo M, Bushnik T, Naro F, Sette C, Hess M, Shelton ER, Conti M. 1998. Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain. Mol Pharmacol 53: 2332.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402408.
  • Mehats C, Andersen CB, Filopanti M, Jin SL, Conti M. 2002. Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab 13: 2935.
  • Mehats C, Jin SL, Wahlstrom J, Law E, Umetsu DT, Conti M. 2003. PDE4D plays a critical role in the control of airway smooth muscle contraction. Faseb J 17: 18311841.
  • Mehats C, Franco-Montoya ML, Boucherat O, Lopez E, Schmitz T, Zana E, Evain-Brion D, Bourbon J, Delacourt C, Jarreau PH. 2008. Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn rats. PLoS ONE 3: e3445.
  • Mendelson CR. 2000. Role of transcription factors in fetal lung development and surfactant protein gene expression. Annu Rev Physiol 62: 875915.
  • Odom MJ, Snyder JM, Mendelson CR. 1987. Adenosine 3′,5′-monophosphate analogs and beta-adrenergic agonists induce the synthesis of the major surfactant apoprotein in human fetal lung in vitro. Endocrinology 121: 11551163.
  • Richter W, Jin SL, Conti M. 2005. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue. Biochem J 388: 803811.
  • Richter W, Day P, Agrawal R, Bruss MD, Granier S, Wang YL, Rasmussen SG, Horner K, Wang P, Lei T, Patterson AJ, Kobilka B, Conti M. 2008. Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4. Embo J 27: 384393.
  • Spina D. 2008. PDE4 inhibitors: current status. Br J Pharmacol 155: 308315.
  • Thompson WJ, Brooker G, Appleman MM. 1974. Assay of cyclic nucleotide phosphodiesterases with radioactive substrates. Methods Enzymol 38: 205212.
  • van Rees EP, van der Ende MB, Sminia T. 1991. Ontogeny of macrophage subpopulations and Ia-positive dendritic cells in pulmonary tissue of the rat. Cell Tissue Res 263: 367373.
  • Wang P, Wu P, Ohleth KM, Egan RW, Billah MM. 1999. Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol 56: 170174.
  • Whitsett JA, Machulskis A, Noguchi A, Burdsall JA. 1982a. Ontogeny of alpha 1- and beta-adrenergic receptors in rat lung. Life Sci 30: 139145.
  • Whitsett JA, Noguchi A, Moore JJ. 1982b. Developmental aspects of alpha- and beta-adrenergic receptors. Semin Perinatol 6: 125141.
  • Whitsett JA, Matz S, Darovec-Beckerman C. 1983. cAMP-dependent protein kinase and protein phosphorylation in developing rat lung. Pediatr Res 17: 959966.
  • Whitsett JA, Hull W, Dion C, Lessard J. 1985. cAMP dependent actin phosphorylation in developing rat lung and type II epithelial cells. Exp Lung Res 9: 191209.